Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy

NCT06060561 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06060561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Suspended
Start date
May 30, 2023
Completion date
June 30, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma